Disease | acrocephalosyndactyly |
Comorbidity | C0002895|sickle cell disease |
Sentences | 2 |
PubMedID- 25667774 | acs is a leading cause of mortality in sickle cell disease even among nigerian patients, accounting for about 25% of all deaths [83–85]. |
PubMedID- 21464764 | Conclusions: when nalbuphine is used alone as the single parenteral opioid agent to treat painful episodes in patients with sickle cell disease, the incidence of acs is less than when compared with other opioids used to treat pain. |
Page: 1